46.26 USD
-1.52
3.18%
Updated Mar 12, 3:55 PM EDT
1 day
-3.18%
5 days
37.35%
1 month
34.05%
3 months
-7.03%
6 months
77.24%
Year to date
-0.22%
1 year
166.94%
5 years
168.17%
10 years
2,092.42%
 

About: Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Employees: 148

0
Funds holding %
of 7,363 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

92% more capital invested

Capital invested by funds: $16.7M [Q3] → $32M (+$15.3M) [Q4]

75% more funds holding

Funds holding: 24 [Q3] → 42 (+18) [Q4]

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

4.49% more ownership

Funds ownership: 16.65% [Q3] → 21.14% (+4.49%) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for PDEX.

Financial journalist opinion

Positive
Zacks Investment Research
1 week ago
ProDex (PDEX) Upgraded to Strong Buy: Here's What You Should Know
ProDex (PDEX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ProDex (PDEX) Upgraded to Strong Buy: Here's What You Should Know
Positive
Seeking Alpha
1 month ago
Q4 2024 Portfolio Update: Growth Has Come Patiently
In 4Q24, we crossed $10M in AUM, emphasizing patient growth and strategic portfolio management, with a focus on long-term investments and five-year doubles. Key drivers include CCRD, PDEX, and RSSS, with CoreCard benefiting from a new contract with Goldman, and Pro-Dex showing strong business performance. Matrix Service is expected to convert backlog to profit in the next 18-24 months, while new positions are anticipated to start small.
Q4 2024 Portfolio Update: Growth Has Come Patiently
Positive
Zacks Investment Research
1 month ago
Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.14 per share a year ago.
Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates
Neutral
Accesswire
1 month ago
Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 second quarter ended December 31, 2024.
Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
Positive
Zacks Investment Research
1 month ago
All You Need to Know About ProDex (PDEX) Rating Upgrade to Buy
ProDex (PDEX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About ProDex (PDEX) Rating Upgrade to Buy
Positive
Zacks Investment Research
2 months ago
ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
Positive
Zacks Investment Research
2 months ago
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
Investors can consider investing in PDEX right now as the stock has done extremely well through 2024 and its prospects continue to shine.
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
Positive
Zacks Investment Research
2 months ago
Best Momentum Stocks to Buy for January 6th
NRXP, PDEX and PBYI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6, 2024.
Best Momentum Stocks to Buy for January 6th
Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 6th
ALK, AHT, NRXP, PDEX and EGAN have been added to the Zacks Rank #1 (Strong Buy) List on January 6, 2024.
New Strong Buy Stocks for January 6th
Neutral
Accesswire
4 months ago
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024.
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
Charts implemented using Lightweight Charts™